188 related articles for article (PubMed ID: 37906565)
1. The risk of bleeding and perforation from sigmoidoscopy or colonoscopy in colorectal cancer screening: A systematic review and meta-analyses.
Kindt IS; Martiny FHJ; Gram EG; Bie AKL; Jauernik CP; Rahbek OJ; Nielsen SB; Siersma V; Bang CW; Brodersen JB
PLoS One; 2023; 18(10):e0292797. PubMed ID: 37906565
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study.
Buskermolen M; Cenin DR; Helsingen LM; Guyatt G; Vandvik PO; Haug U; Bretthauer M; Lansdorp-Vogelaar I
BMJ; 2019 Oct; 367():l5383. PubMed ID: 31578177
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis.
Jodal HC; Helsingen LM; Anderson JC; Lytvyn L; Vandvik PO; Emilsson L
BMJ Open; 2019 Oct; 9(10):e032773. PubMed ID: 31578199
[TBL] [Abstract][Full Text] [Related]
4. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Lin JS; Perdue LA; Henrikson NB; Bean SI; Blasi PR
JAMA; 2021 May; 325(19):1978-1998. PubMed ID: 34003220
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline.
Helsingen LM; Vandvik PO; Jodal HC; Agoritsas T; Lytvyn L; Anderson JC; Auer R; Murphy SB; Almadi MA; Corley DA; Quinlan C; Fuchs JM; McKinnon A; Qaseem A; Heen AF; Siemieniuk RAC; Kalager M; Usher-Smith JA; Lansdorp-Vogelaar I; Bretthauer M; Guyatt G
BMJ; 2019 Oct; 367():l5515. PubMed ID: 31578196
[TBL] [Abstract][Full Text] [Related]
6. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals.
Holme Ø; Bretthauer M; Fretheim A; Odgaard-Jensen J; Hoff G
Cochrane Database Syst Rev; 2013 Oct; 2013(9):CD009259. PubMed ID: 24085634
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Adherence to colonoscopy in cascade screening of colorectal cancer: A systematic review and meta-analysis.
Wu W; Huang J; Yang Y; Gu K; Luu HN; Tan S; Yang C; Fu J; Bao P; Ying T; Withers M; Mao D; Chen S; Gong Y; Wong MCS; Xu W
J Gastroenterol Hepatol; 2022 Apr; 37(4):620-631. PubMed ID: 34907588
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of flexible sigmoidoscopy combined with fecal immunochemical test in colorectal cancer screening: meta-analysis and modeling.
Niedermaier T; Weigl K; Hoffmeister M; Brenner H
Eur J Epidemiol; 2017 Jun; 32(6):481-493. PubMed ID: 28667446
[TBL] [Abstract][Full Text] [Related]
10. Screening for colorectal cancer using the faecal occult blood test, hemoccult.
Towler BP; Irwig L; Glasziou P; Weller D; Kewenter J
Cochrane Database Syst Rev; 2000; (2):CD001216. PubMed ID: 10796760
[TBL] [Abstract][Full Text] [Related]
11. Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study.
Gatto NM; Frucht H; Sundararajan V; Jacobson JS; Grann VR; Neugut AI
J Natl Cancer Inst; 2003 Feb; 95(3):230-6. PubMed ID: 12569145
[TBL] [Abstract][Full Text] [Related]
12. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
13. Screening for Colorectal Cancer: A Systematic Review and Meta-Analysis.
Fitzpatrick-Lewis D; Ali MU; Warren R; Kenny M; Sherifali D; Raina P
Clin Colorectal Cancer; 2016 Dec; 15(4):298-313. PubMed ID: 27133893
[TBL] [Abstract][Full Text] [Related]
14. Colorectal Cancer Screening With Repeated Fecal Immunochemical Test Versus Sigmoidoscopy: Baseline Results From a Randomized Trial.
Randel KR; Schult AL; Botteri E; Hoff G; Bretthauer M; Ursin G; Natvig E; Berstad P; Jørgensen A; Sandvei PK; Olsen ME; Frigstad SO; Darre-Næss O; Norvard ER; Bolstad N; Kørner H; Wibe A; Wensaas KA; de Lange T; Holme Ø
Gastroenterology; 2021 Mar; 160(4):1085-1096.e5. PubMed ID: 33227280
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer screening.
Bretthauer M
J Intern Med; 2011 Aug; 270(2):87-98. PubMed ID: 21575082
[TBL] [Abstract][Full Text] [Related]
16. Fecal occult blood and flexible sigmoidoscopy screening for colorectal cancer: modeling the impact on colonoscopy requirements and cancer detection rates.
Olynyk JK; Platell CF; Collett JA
J Gastroenterol Hepatol; 2001 Apr; 16(4):389-92. PubMed ID: 11354276
[TBL] [Abstract][Full Text] [Related]
17. Deaths and cardiopulmonary events following colorectal cancer screening-A systematic review with meta-analyses.
Martiny FHJ; Bie AKL; Jauernik CP; Rahbek OJ; Nielsen SB; Gram EG; Kindt I; Siersma V; Bang CW; Brodersen JB
PLoS One; 2024; 19(3):e0295900. PubMed ID: 38483910
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
